Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hamed Rezaei
With
Abbott
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patient (\> 18 years of age), male or female
Rheumatoid arthritis according to the 1987 ACR or 2010 EULAR/ACR classification criteria
Moderate to high disease activity
Ongoing anti-rheumatic treatment with DMARD, with stable dosage during the last 3 months, and being a candidate for anti-TNF add-on therapy OR ongoing treatment with first anti-TNF therapy and being a candidate for switch to another anti-TNF therapy
Women with child-bearing potential: use of an adequate method of contraception to avoid pregnancy throughout the study
Signed Informed Consent \*Signed Informed Consent must be obtained before any study specific procedures take place.
You may not be if
Biologic treatment with Adalimumab before inclusion
Two or more ongoing biologic treatments before inclusion
Treatment with other biologic treatment than anti-TNF therapy before inclusion
Any contraindication for treatment with Adalimumab
Intraarticular corticosteroid injection during the last 4 weeks before each follow-up visit
